Literature DB >> 163793

Naturally occurring persistent feline oncornavirus infections in the absence of disease.

M Essex, W D Hardy, S M Cotter, R M Jakowski, A Sliski.   

Abstract

Healthy feline leukemia virus (FeLV)-infected cats from leukemia cluster environments were followed for up to 23 months for development of disease and evidence of alteration in the hemogram. The incidence of disease development in FeLV-postive cats was more than fivefold higher than the incidence for FeLV-negative cats. Ten cases of leukemia developed in 69 infected cats, whereas one case of leukemia occurred in 59 uninfected cats. The incidence for development of diseases other than leukemia was 30.4 percent for FeLV-infected cats as opposed to 6.8 per cent for uninfected cats. This could be a result of the immunosuppressive effects of FeLV. Felv-infected cats had no evidence of subclinical anemia. Mean packed cell volumes and total leukocyte counts were about the same for infected and uninfected animals. The only variation seen in healthy FeLV-infected cats was a decreased mean lymphocyte count. The difference between mean lymphocyte count for FeLV-infected and uninfected animals was significant at the 0.999 level. These findings suggest that the incubation period for feline leukemia may be very prolonged under natural conditions and that an increased susceptibility to unrelated infectious diseases exists during this period. This increased susceptibility was apparently not associated with anemia or depressed total leukocyte counts.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163793      PMCID: PMC415088          DOI: 10.1128/iai.11.3.470-475.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Multiple cases of feline leukemia and feline infectious peritonitis in a household.

Authors:  S M Cotter; C E Gilmore; C Rollins
Journal:  J Am Vet Med Assoc       Date:  1973-06-15       Impact factor: 1.936

2.  Serological studies of normal and leukemic cats in a multiple-case leukemia cluster.

Authors:  S M Cotter; M Essex; W D Hardy
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

3.  Feline leukemia.

Authors:  W Jarrett
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1972

4.  Feline oncornavirus-associated cell membrane antigen. I. Serologic studies with kittens exposed to cell-free materials from various feline fibrosarcomas.

Authors:  M Essex; S P Snyder
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

5.  Horizontal transmission of leukemia virus and leukemia in the cat.

Authors:  W Jarrett; O Jarrett; L Mackey; H Laird; W Hardy; M Essex
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

6.  Correlation between humoral antibody and regression of tumours induced by feline sarcoma virus.

Authors:  M Essex; G Klein; S P Snyder; J B Harrold
Journal:  Nature       Date:  1971-09-17       Impact factor: 49.962

Review 7.  Naturally occurring feline leukemia: clinical, pathologic, and differential diagnostic features.

Authors:  C E Gilmore; J Holzworth
Journal:  J Am Vet Med Assoc       Date:  1971-03-15       Impact factor: 1.936

8.  A study of immunity against pasteurella multocida in buffalo calves and their carrier status.

Authors:  K Mohan; M N Sinha; R P Singh; C M Gupta
Journal:  Vet Rec       Date:  1968-08-10       Impact factor: 2.695

9.  Antibody to feline oncornavirus-associated cell membrane antigen in neonatal cats.

Authors:  M Essex; G Klein; S P Snyder; J B Harrold
Journal:  Int J Cancer       Date:  1971-11-15       Impact factor: 7.396

Review 10.  Relationship between humoral antibodies and the failure to develop progressive tumors in cats injected with feline sarcoma virus (FSV).

Authors:  M Essex; S P Snyder; G Klein
Journal:  Bibl Haematol       Date:  1973
View more
  13 in total

Review 1.  Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.

Authors:  E G Sandström; J C Kaplan
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

2.  Influence of inactivated feline retrovirus on feline alpha interferon and immunoglobulin production.

Authors:  M Yasuda; R A Good; N K Day
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

3.  Animal model: feline acute lymphoblastic leukemia and aplastic anemia.

Authors:  S M Cotter; M Essex
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

4.  The acquired immunodeficiency syndrome (AIDS).

Authors:  F S Rosen
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

Review 5.  Immunopathology induced by the feline leukemia virus.

Authors:  W D Hardy
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Humoral immune response of asymptomatic cats naturally infected with feline leukemia virus.

Authors:  D Wernicke; Z Trainin; H Ungar-Waron; M Essex
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A.

Authors:  R W Engelman; R D Tyler; L Q Trang; W T Liu; R A Good; N K Day
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

8.  Inhibition of phorbol ester-induced neutrophil chemiluminescence by FeLV.

Authors:  C S Dezzutti; L J Lafrado; M G Lewis; R G Olsen
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

9.  Age-related differences in pharmacokinetics of phosphonoformate in cats.

Authors:  C L Swenson; R A Sams; P J Polas; D F Michael; L E Mathes
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 10.  Autopsy pathology in the acquired immune deficiency syndrome.

Authors:  C M Reichert; T J O'Leary; D L Levens; C R Simrell; A M Macher
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.